Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 2.700
-0.170 (-5.92%)
Aug 28, 2026, 4:00 PM EST
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
315.42M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.19B |
| Cresco Labs | 924.67M |
| TerrAscend | 374.77M |
| Aurora Cannabis | 314.07M |
| Organigram Global | 309.18M |
| Canopy Growth | 293.63M |
| Auxly Cannabis Group | 165.57M |
| Medexus Pharmaceuticals | 146.70M |
Cardiol Therapeutics News
- 4 days ago - Cardiol Therapeutics initiated with a Buy at B. Riley - TheFly
- 13 days ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 13 days ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 13 days ago - Cardiol Therapeutics price target raised to $10 from $8 at Canaccord - TheFly
- 18 days ago - Cardiol Therapeutics Registration statement: Q2 2026 - Filings
- 18 days ago - Cardiol Therapeutics Registration statement: Q2 2026 - Filings
- 18 days ago - Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial - MarketBeat
- 19 days ago - Cardiol Therapeutics Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts